Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 280

1.

The Relationship Between Polygenic Risk Scores and Cognition in Schizophrenia.

Richards AL, Pardiñas AF, Frizzati A, Tansey KE, Lynham AJ, Holmans P, Legge SE, Savage JE, Agartz I, Andreassen OA, Blokland GAM, Corvin A, Cosgrove D, Degenhardt F, Djurovic S, Espeseth T, Ferraro L, Gayer-Anderson C, Giegling I, van Haren NE, Hartmann AM, Hubert JJ, Jönsson EG, Konte B, Lennertz L, Olde Loohuis LM, Melle I, Morgan C, Morris DW, Murray RM, Nyman H, Ophoff RA; GROUP Investigators, van Os J; EUGEI WP2 Group; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Petryshen TL, Quattrone D, Rietschel M, Rujescu D, Rutten BPF, Streit F, Strohmaier J, Sullivan PF, Sundet K, Wagner M, Escott-Price V, Owen MJ, Donohoe G, O'Donovan MC, Walters JTR.

Schizophr Bull. 2019 Jun 17. pii: sbz061. doi: 10.1093/schbul/sbz061. [Epub ahead of print]

PMID:
31206164
2.

GWAS of Suicide Attempt in Psychiatric Disorders and Association With Major Depression Polygenic Risk Scores.

Mullins N, Bigdeli TB, Børglum AD, Coleman JRI, Demontis D, Mehta D, Power RA, Ripke S, Stahl EA, Starnawska A, Anjorin A; M.R.C.Psych, Corvin A, Sanders AR, Forstner AJ, Reif A, Koller AC, Świątkowska B, Baune BT, Müller-Myhsok B, Penninx BWJH, Pato C, Zai C, Rujescu D, Hougaard DM, Quested D, Levinson DF, Binder EB, Byrne EM, Agerbo E; Dr.Med.Sc, Streit F, Mayoral F, Bellivier F, Degenhardt F, Breen G, Morken G, Turecki G, Rouleau GA, Grabe HJ, Völzke H, Jones I, Giegling I, Agartz I, Melle I, Lawrence J; M.R.C.Psych, Walters JTR, Strohmaier J, Shi J, Hauser J, Biernacka JM, Vincent JB, Kelsoe J, Strauss JS, Lissowska J, Pimm J; M.R.C.Psych, Smoller JW, Guzman-Parra J, Berger K, Scott LJ, Jones LA, Azevedo MH, Trzaskowski M, Kogevinas M, Rietschel M, Boks M, Ising M, Grigoroiu-Serbanescu M, Hamshere ML, Leboyer M, Frye M, Nöthen MM, Alda M, Preisig M, Nordentoft M, Boehnke M, O'Donovan MC, Owen MJ, Pato MT, Renteria ME, Budde M; Dipl.-Psych, Weissman MM, Wray NR, Bass N; M.R.C.Psych, Craddock N, Smeland OB, Andreassen OA, Mors O, Gejman PV, Sklar P, McGrath P, Hoffmann P, McGuffin P, Lee PH, Mortensen PB, Kahn RS, Ophoff RA, Adolfsson R, Van der Auwera S, Djurovic S, Kloiber S, Heilmann-Heimbach S, Jamain S, Hamilton SP, McElroy SL, Lucae S, Cichon S, Schulze TG, Hansen T, Werge T, Air TM, Nimgaonkar V, Appadurai V, Cahn W, Milaneschi Y; Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium; Schizophrenia Working Group of the Psychiatric Genomics Consortium, Fanous AH, Kendler KS, McQuillin A, Lewis CM.

Am J Psychiatry. 2019 Jun 5:appiajp201918080957. doi: 10.1176/appi.ajp.2019.18080957. [Epub ahead of print]

PMID:
31164008
3.
4.

A preliminary study of cortical morphology in schizophrenia patients with a history of violence.

Storvestre GB, Valnes LM, Jensen A, Nerland S, Tesli N, Hymer KE, Rosaeg C, Server A, Ringen PA, Jacobsen M, Andreassen OA, Agartz I, Melle I, Haukvik UK.

Psychiatry Res Neuroimaging. 2019 Jun 30;288:29-36. doi: 10.1016/j.pscychresns.2019.04.013. Epub 2019 May 1.

PMID:
31071542
5.

Genome-wide association study identifies 30 loci associated with bipolar disorder.

Stahl EA, Breen G, Forstner AJ, McQuillin A, Ripke S, Trubetskoy V, Mattheisen M, Wang Y, Coleman JRI, Gaspar HA, de Leeuw CA, Steinberg S, Pavlides JMW, Trzaskowski M, Byrne EM, Pers TH, Holmans PA, Richards AL, Abbott L, Agerbo E, Akil H, Albani D, Alliey-Rodriguez N, Als TD, Anjorin A, Antilla V, Awasthi S, Badner JA, Bækvad-Hansen M, Barchas JD, Bass N, Bauer M, Belliveau R, Bergen SE, Pedersen CB, Bøen E, Boks MP, Boocock J, Budde M, Bunney W, Burmeister M, Bybjerg-Grauholm J, Byerley W, Casas M, Cerrato F, Cervantes P, Chambert K, Charney AW, Chen D, Churchhouse C, Clarke TK, Coryell W, Craig DW, Cruceanu C, Curtis D, Czerski PM, Dale AM, de Jong S, Degenhardt F, Del-Favero J, DePaulo JR, Djurovic S, Dobbyn AL, Dumont A, Elvsåshagen T, Escott-Price V, Fan CC, Fischer SB, Flickinger M, Foroud TM, Forty L, Frank J, Fraser C, Freimer NB, Frisén L, Gade K, Gage D, Garnham J, Giambartolomei C, Pedersen MG, Goldstein J, Gordon SD, Gordon-Smith K, Green EK, Green MJ, Greenwood TA, Grove J, Guan W, Guzman-Parra J, Hamshere ML, Hautzinger M, Heilbronner U, Herms S, Hipolito M, Hoffmann P, Holland D, Huckins L, Jamain S, Johnson JS, Juréus A, Kandaswamy R, Karlsson R, Kennedy JL, Kittel-Schneider S, Knowles JA, Kogevinas M, Koller AC, Kupka R, Lavebratt C, Lawrence J, Lawson WB, Leber M, Lee PH, Levy SE, Li JZ, Liu C, Lucae S, Maaser A, MacIntyre DJ, Mahon PB, Maier W, Martinsson L, McCarroll S, McGuffin P, McInnis MG, McKay JD, Medeiros H, Medland SE, Meng F, Milani L, Montgomery GW, Morris DW, Mühleisen TW, Mullins N, Nguyen H, Nievergelt CM, Adolfsson AN, Nwulia EA, O'Donovan C, Loohuis LMO, Ori APS, Oruc L, Ösby U, Perlis RH, Perry A, Pfennig A, Potash JB, Purcell SM, Regeer EJ, Reif A, Reinbold CS, Rice JP, Rivas F, Rivera M, Roussos P, Ruderfer DM, Ryu E, Sánchez-Mora C, Schatzberg AF, Scheftner WA, Schork NJ, Shannon Weickert C, Shehktman T, Shilling PD, Sigurdsson E, Slaney C, Smeland OB, Sobell JL, Søholm Hansen C, Spijker AT, St Clair D, Steffens M, Strauss JS, Streit F, Strohmaier J, Szelinger S, Thompson RC, Thorgeirsson TE, Treutlein J, Vedder H, Wang W, Watson SJ, Weickert TW, Witt SH, Xi S, Xu W, Young AH, Zandi P, Zhang P, Zöllner S; eQTLGen Consortium; BIOS Consortium, Adolfsson R, Agartz I, Alda M, Backlund L, Baune BT, Bellivier F, Berrettini WH, Biernacka JM, Blackwood DHR, Boehnke M, Børglum AD, Corvin A, Craddock N, Daly MJ, Dannlowski U, Esko T, Etain B, Frye M, Fullerton JM, Gershon ES, Gill M, Goes F, Grigoroiu-Serbanescu M, Hauser J, Hougaard DM, Hultman CM, Jones I, Jones LA, Kahn RS, Kirov G, Landén M, Leboyer M, Lewis CM, Li QS, Lissowska J, Martin NG, Mayoral F, McElroy SL, McIntosh AM, McMahon FJ, Melle I, Metspalu A, Mitchell PB, Morken G, Mors O, Mortensen PB, Müller-Myhsok B, Myers RM, Neale BM, Nimgaonkar V, Nordentoft M, Nöthen MM, O'Donovan MC, Oedegaard KJ, Owen MJ, Paciga SA, Pato C, Pato MT, Posthuma D, Ramos-Quiroga JA, Ribasés M, Rietschel M, Rouleau GA, Schalling M, Schofield PR, Schulze TG, Serretti A, Smoller JW, Stefansson H, Stefansson K, Stordal E, Sullivan PF, Turecki G, Vaaler AE, Vieta E, Vincent JB, Werge T, Nurnberger JI, Wray NR, Di Florio A, Edenberg HJ, Cichon S, Ophoff RA, Scott LJ, Andreassen OA, Kelsoe J, Sklar P; Bipolar Disorder Working Group of the Psychiatric Genomics Consortium.

Nat Genet. 2019 May;51(5):793-803. doi: 10.1038/s41588-019-0397-8. Epub 2019 May 1.

PMID:
31043756
6.

Antipsychotic treatment and basal ganglia volumes: Exploring the role of receptor occupancy, dosage and remission status.

Di Sero A, Jørgensen KN, Nerland S, Melle I, Andreassen OA, Jovicich J, Agartz I.

Schizophr Res. 2019 Jun;208:114-123. doi: 10.1016/j.schres.2019.04.002. Epub 2019 Apr 18.

PMID:
31006616
7.

Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk.

Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT; Karolinska Schizophrenia Project Consortium.

JAMA Psychiatry. 2019 Apr 10. doi: 10.1001/jamapsychiatry.2019.0257. [Epub ahead of print]

PMID:
30969333
8.
9.

N-BiC: A method for multi-component and symptom biclustering of structural MRI data: Application to schizophrenia.

Rahaman MA, Turner JA, Gupta CN, Rachakonda S, Chen J, Liu JY, van Erp TGM, Potkin S, Ford JM, Mathalon DH, Lee HJ, Jiang W, Mueller B, Andreassen O, Agartz I, Sponheim SR, Mayer A, Stephen JM, Jung R, Canive J, Bustillo J, Calhoun VD.

IEEE Trans Biomed Eng. 2019 Apr 1. doi: 10.1109/TBME.2019.2908815. [Epub ahead of print]

PMID:
30946659
10.

Telomere length is associated with childhood trauma in patients with severe mental disorders.

Aas M, Elvsåshagen T, Westlye LT, Kaufmann T, Athanasiu L, Djurovic S, Melle I, van der Meer D, Martin-Ruiz C, Steen NE, Agartz I, Andreassen OA.

Transl Psychiatry. 2019 Mar 21;9(1):97. doi: 10.1038/s41398-019-0432-7.

11.

Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.

Steen NE, Dieset I, Hope S, Vedal TSJ, Smeland OB, Matson W, Kaddurah-Daouk R, Agartz I, Melle I, Djurovic S, Jönsson EG, Bogdanov M, Andreassen OA.

Psychol Med. 2019 Mar 14:1-12. doi: 10.1017/S0033291719000400. [Epub ahead of print]

PMID:
30867076
12.

Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia.

Mennigen E, Jiang W, Calhoun VD, van Erp TGM, Agartz I, Ford JM, Mueller BA, Liu J, Turner JA.

Schizophr Res. 2019 Jun;208:242-249. doi: 10.1016/j.schres.2019.02.010. Epub 2019 Feb 26.

PMID:
30819594
13.

Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors - ERRATUM.

Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA.

Psychol Med. 2019 Jul;49(10):1758. doi: 10.1017/S0033291719000291. Epub 2019 Feb 26. No abstract available.

PMID:
30803457
14.

Correction: Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

Sønderby IE, Gústafsson Ó, Doan NT, Hibar DP, Martin-Brevet S, Abdellaoui A, Ames D, Amunts K, Andersson M, Armstrong NJ, Bernard M, Blackburn N, Blangero J, Boomsma DI, Bralten J, Brattbak HR, Brodaty H, Brouwer RM, Bülow R, Calhoun V, Caspers S, Cavalleri G, Chen CH, Cichon S, Ciufolini S, Corvin A, Crespo-Facorro B, Curran JE, Dale AM, Dalvie S, Dazzan P, de Geus EJC, de Zubicaray GI, de Zwarte SMC, Delanty N, den Braber A, Desrivières S, Donohoe G, Draganski B, Ehrlich S, Espeseth T, Fisher SE, Franke B, Frouin V, Fukunaga M, Gareau T, Glahn DC, Grabe H, Groenewold NA, Haavik J, Håberg A, Hashimoto R, Hehir-Kwa JY, Heinz A, Hillegers MHJ, Hoffmann P, Holleran L, Hottenga JJ, Hulshoff HE, Ikeda M, Jahanshad N, Jernigan T, Jockwitz C, Johansson S, Jonsdottir GA, Jönsson EG, Kahn R, Kaufmann T, Kelly S, Kikuchi M, Knowles EEM, Kolskår KK, Kwok JB, Hellard SL, Leu C, Liu J, Lundervold AJ, Lundervold A, Martin NG, Mather K, Mathias SR, McCormack M, McMahon KL, McRae A, Milaneschi Y, Moreau C, Morris D, Mothersill D, Mühleisen TW, Murray R, Nordvik JE, Nyberg L, Olde Loohuis LM, Ophoff R, Paus T, Pausova Z, Penninx B, Peralta JM, Pike B, Prieto C, Pudas S, Quinlan E, Quintana DS, Reinbold CS, Marques TR, Reymond A, Richard G, Rodriguez-Herreros B, Roiz-Santiañez R, Rokicki J, Rucker J, Sachdev P, Sanders AM, Sando SB, Schmaal L, Schofield PR, Schork AJ, Schumann G, Shin J, Shumskaya E, Sisodiya S, Steen VM, Stein DJ, Steinberg S, Strike L, Teumer A, Thalamuthu A, Tordesillas-Gutierrez D, Turner J, Ueland T, Uhlmann A, Ulfarsson MO, van 't Ent D, van der Meer D, van Haren NEM, Vaskinn A, Vassos E, Walters GB, Wang Y, Wen W, Whelan CD, Wittfeld K, Wright M, Yamamori H, Zayats T, Agartz I, Westlye LT, Jacquemont S, Djurovic S, Stefánsson H, Stefánsson K, Thompson P, Andreassen OA; 16p11.2 European Consortium, for the ENIGMA-CNV working group.

Mol Psychiatry. 2019 Jan 31. doi: 10.1038/s41380-019-0358-8. [Epub ahead of print]

PMID:
30705424
15.

White matter microstructure in schizophrenia patients with a history of violence.

Tesli N, Westlye LT, Storvestre GB, Gurholt TP, Agartz I, Melle I, Andreassen OA, Haukvik UK.

Eur Arch Psychiatry Clin Neurosci. 2019 Jan 29. doi: 10.1007/s00406-019-00988-0. [Epub ahead of print]

PMID:
30694361
16.

Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors.

Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA.

Psychol Med. 2019 Jul;49(10):1749-1757. doi: 10.1017/S0033291718004142. Epub 2019 Jan 28.

PMID:
30688187
17.

Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder.

Schwarz E, Doan NT, Pergola G, Westlye LT, Kaufmann T, Wolfers T, Brecheisen R, Quarto T, Ing AJ, Di Carlo P, Gurholt TP, Harms RL, Noirhomme Q, Moberget T, Agartz I, Andreassen OA, Bellani M, Bertolino A, Blasi G, Brambilla P, Buitelaar JK, Cervenka S, Flyckt L, Frangou S, Franke B, Hall J, Heslenfeld DJ, Kirsch P, McIntosh AM, Nöthen MM, Papassotiropoulos A, de Quervain DJ, Rietschel M, Schumann G, Tost H, Witt SH, Zink M, Meyer-Lindenberg A; IMAGEMEND Consortium, Karolinska Schizophrenia Project (KaSP) Consortium.

Transl Psychiatry. 2019 Jan 17;9(1):12. doi: 10.1038/s41398-018-0225-4.

18.

Elevated hair cortisol is associated with childhood maltreatment and cognitive impairment in schizophrenia and in bipolar disorders.

Aas M, Pizzagalli DA, Laskemoen JF, Reponen EJ, Ueland T, Melle I, Agartz I, Steen NE, Andreassen OA.

Schizophr Res. 2019 Jan 16. pii: S0920-9964(19)30011-8. doi: 10.1016/j.schres.2019.01.011. [Epub ahead of print]

PMID:
30660575
19.

The relationship between physical activity, clinical and cognitive characteristics and BDNF mRNA levels in patients with severe mental disorders.

Aas M, Djurovic S, Ueland T, Mørch RH, Laskemoen JF, Reponen EJ, Cattaneo A, Steen NE, Agartz I, Melle I, Andreassen OA.

World J Biol Psychiatry. 2018 Dec 18:1-24. doi: 10.1080/15622975.2018.1557345. [Epub ahead of print]

PMID:
30560709
20.

Association between olanzapine treatment and brain cortical thickness and gray/white matter contrast is moderated by cholesterol in psychotic disorders.

Gjerde PB, Jørgensen KN, Steen NE, Melle I, Andreassen OA, Steen VM, Agartz I.

Psychiatry Res Neuroimaging. 2018 Dec 30;282:55-63. doi: 10.1016/j.pscychresns.2018.10.001. Epub 2018 Oct 29.

PMID:
30415175
21.

An association between YKL-40 and type 2 diabetes in psychotic disorders.

Dieset I, Mørch RH, Hope S, Hoseth EZ, Reponen EJ, Gran JM, Aas M, Michelsen AE, Reichborn-Kjennerud T, Nesvåg R, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA.

Acta Psychiatr Scand. 2019 Jan;139(1):37-45. doi: 10.1111/acps.12971. Epub 2018 Oct 17.

PMID:
30328100
22.

Mapping the Heterogeneous Phenotype of Schizophrenia and Bipolar Disorder Using Normative Models.

Wolfers T, Doan NT, Kaufmann T, Alnæs D, Moberget T, Agartz I, Buitelaar JK, Ueland T, Melle I, Franke B, Andreassen OA, Beckmann CF, Westlye LT, Marquand AF.

JAMA Psychiatry. 2018 Nov 1;75(11):1146-1155. doi: 10.1001/jamapsychiatry.2018.2467.

PMID:
30304337
23.

Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

Sønderby IE, Gústafsson Ó, Doan NT, Hibar DP, Martin-Brevet S, Abdellaoui A, Ames D, Amunts K, Andersson M, Armstrong NJ, Bernard M, Blackburn N, Blangero J, Boomsma DI, Bralten J, Brattbak HR, Brodaty H, Brouwer RM, Bülow R, Calhoun V, Caspers S, Cavalleri G, Chen CH, Cichon S, Ciufolini S, Corvin A, Crespo-Facorro B, Curran JE, Dale AM, Dalvie S, Dazzan P, de Geus EJC, de Zubicaray GI, de Zwarte SMC, Delanty N, den Braber A, Desrivières S, Donohoe G, Draganski B, Ehrlich S, Espeseth T, Fisher SE, Franke B, Frouin V, Fukunaga M, Gareau T, Glahn DC, Grabe H, Groenewold NA, Haavik J, Håberg A, Hashimoto R, Hehir-Kwa JY, Heinz A, Hillegers MHJ, Hoffmann P, Holleran L, Hottenga JJ, Hulshoff HE, Ikeda M, Jahanshad N, Jernigan T, Jockwitz C, Johansson S, Jonsdottir GA, Jönsson EG, Kahn R, Kaufmann T, Kelly S, Kikuchi M, Knowles EEM, Kolskår KK, Kwok JB, Hellard SL, Leu C, Liu J, Lundervold AJ, Lundervold A, Martin NG, Mather K, Mathias SR, McCormack M, McMahon KL, McRae A, Milaneschi Y, Moreau C, Morris D, Mothersill D, Mühleisen TW, Murray R, Nordvik JE, Nyberg L, Olde Loohuis LM, Ophoff R, Paus T, Pausova Z, Penninx B, Peralta JM, Pike B, Prieto C, Pudas S, Quinlan E, Quintana DS, Reinbold CS, Marques TR, Reymond A, Richard G, Rodriguez-Herreros B, Roiz-Santiañez R, Rokicki J, Rucker J, Sachdev P, Sanders AM, Sando SB, Schmaal L, Schofield PR, Schork AJ, Schumann G, Shin J, Shumskaya E, Sisodiya S, Steen VM, Stein DJ, Steinberg S, Strike L, Teumer A, Thalamuthu A, Tordesillas-Gutierrez D, Turner J, Ueland T, Uhlmann A, Ulfarsson MO, van 't Ent D, van der Meer D, van Haren NEM, Vaskinn A, Vassos E, Walters GB, Wang Y, Wen W, Whelan CD, Wittfeld K, Wright M, Yamamori H, Zayats T, Agartz I, Westlye LT, Jacquemont S, Djurovic S, Stefánsson H, Stefánsson K, Thompson P, Andreassen OA; 16p11.2 European Consortium, for the ENIGMA-CNV working group.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0118-1. [Epub ahead of print] Erratum in: Mol Psychiatry. 2019 Jan 31;:.

PMID:
30283035
24.

Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes.

van der Meer D, Rokicki J, Kaufmann T, Córdova-Palomera A, Moberget T, Alnæs D, Bettella F, Frei O, Doan NT, Sønderby IE, Smeland OB, Agartz I, Bertolino A, Bralten J, Brandt CL, Buitelaar JK, Djurovic S, van Donkelaar M, Dørum ES, Espeseth T, Faraone SV, Fernández G, Fisher SE, Franke B, Haatveit B, Hartman CA, Hoekstra PJ, Håberg AK, Jönsson EG, Kolskår KK, Le Hellard S, Lund MJ, Lundervold AJ, Lundervold A, Melle I, Monereo Sánchez J, Norbom LC, Nordvik JE, Nyberg L, Oosterlaan J, Papalino M, Papassotiropoulos A, Pergola G, de Quervain DJF, Richard G, Sanders AM, Selvaggi P, Shumskaya E, Steen VM, Tønnesen S, Ulrichsen KM, Zwiers MP, Andreassen OA, Westlye LT; Alzheimer’s Disease Neuroimaging Initiative; Pediatric Imaging, Neurocognition and Genetics Study.

Mol Psychiatry. 2018 Oct 2. doi: 10.1038/s41380-018-0262-7. [Epub ahead of print]

25.

Healthy Adolescent Performance With Standardized Scoring Tables for the MATRICS Consensus Cognitive Battery: A Multisite Study.

Smelror RE, Jørgensen KN, Lonning V, Kelleher I, Cannon M, DeRosse P, Malhotra AK, Karlsgodt KH, Andreassen OA, Lundberg M, Edbom T, Cleland N, Ueland T, Myhre AM, Rund BR, Agartz I.

Schizophr Bull. 2019 Jun 18;45(4):773-783. doi: 10.1093/schbul/sby131.

26.

White matter aberrations and age-related trajectories in patients with schizophrenia and bipolar disorder revealed by diffusion tensor imaging.

Tønnesen S, Kaufmann T, Doan NT, Alnæs D, Córdova-Palomera A, Meer DV, Rokicki J, Moberget T, Gurholt TP, Haukvik UK, Ueland T, Lagerberg TV, Agartz I, Andreassen OA, Westlye LT.

Sci Rep. 2018 Sep 20;8(1):14129. doi: 10.1038/s41598-018-32355-9.

27.

Using structural MRI to identify bipolar disorders - 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group.

Nunes A, Schnack HG, Ching CRK, Agartz I, Akudjedu TN, Alda M, Alnæs D, Alonso-Lana S, Bauer J, Baune BT, Bøen E, Bonnin CDM, Busatto GF, Canales-Rodríguez EJ, Cannon DM, Caseras X, Chaim-Avancini TM, Dannlowski U, Díaz-Zuluaga AM, Dietsche B, Doan NT, Duchesnay E, Elvsåshagen T, Emden D, Eyler LT, Fatjó-Vilas M, Favre P, Foley SF, Fullerton JM, Glahn DC, Goikolea JM, Grotegerd D, Hahn T, Henry C, Hibar DP, Houenou J, Howells FM, Jahanshad N, Kaufmann T, Kenney J, Kircher TTJ, Krug A, Lagerberg TV, Lenroot RK, López-Jaramillo C, Machado-Vieira R, Malt UF, McDonald C, Mitchell PB, Mwangi B, Nabulsi L, Opel N, Overs BJ, Pineda-Zapata JA, Pomarol-Clotet E, Redlich R, Roberts G, Rosa PG, Salvador R, Satterthwaite TD, Soares JC, Stein DJ, Temmingh HS, Trappenberg T, Uhlmann A, van Haren NEM, Vieta E, Westlye LT, Wolf DH, Yüksel D, Zanetti MV, Andreassen OA, Thompson PM, Hajek T; ENIGMA Bipolar Disorders Working Group.

Mol Psychiatry. 2018 Aug 31. doi: 10.1038/s41380-018-0228-9. [Epub ahead of print]

PMID:
30171211
28.

Vitamin D levels, brain volume, and genetic architecture in patients with psychosis.

Berg AO, Jørgensen KN, Nerhus M, Athanasiu L, Popejoy AB, Bettella F, Norbom LCB, Gurholt TP, Dahl SR, Andreassen OA, Djurovic S, Agartz I, Melle I.

PLoS One. 2018 Aug 24;13(8):e0200250. doi: 10.1371/journal.pone.0200250. eCollection 2018.

29.

Reduced brain-derived neurotrophic factor is associated with childhood trauma experiences and number of depressive episodes in severe mental disorders.

Aas M, Dieset I, Mørch R, Steen NE, Hope S, Reponen EJ, Laskemoen JF, Ueland T, Aukrust P, Melle I, Agartz I, Andreassen OA.

Schizophr Res. 2019 Mar;205:45-50. doi: 10.1016/j.schres.2018.08.007. Epub 2018 Aug 17.

PMID:
30126813
30.

Neuroimaging hippocampal subfields in schizophrenia and bipolar disorder: A systematic review and meta-analysis.

Haukvik UK, Tamnes CK, Söderman E, Agartz I.

J Psychiatr Res. 2018 Sep;104:217-226. doi: 10.1016/j.jpsychires.2018.08.012. Epub 2018 Aug 7. Review.

PMID:
30107268
31.

Machine Learning for Large-Scale Quality Control of 3D Shape Models in Neuroimaging.

Petrov D, Gutman BA, Yu SJ, van Erp TGM, Turner JA, Schmaal L, Veltman D, Wang L, Alpert K, Isaev D, Zavaliangos-Petropulu A, Ching CRK, Calhoun V, Glahn D, Satterthwaite TD, Andreasen OA, Borgwardt S, Howells F, Groenewold N, Voineskos A, Radua J, Potkin SG, Crespo-Facorro B, Tordesillas-Gutiérrez D, Shen L, Lebedeva I, Spalletta G, Donohoe G, Kochunov P, Rosa PGP, James A, Dannlowski U, Baune BT, Aleman A, Gotlib IH, Walter H, Walter M, Soares JC, Ehrlich S, Gur RC, Doan NT, Agartz I, Westlye LT, Harrisberger F, Riecher-Rössler A, Uhlmann A, Stein DJ, Dickie EW, Pomarol-Clotet E, Fuentes-Claramonte P, Canales-Rodríguez EJ, Salvador R, Huang AJ, Roiz-Santiañez R, Cong S, Tomyshev A, Piras F, Vecchio D, Banaj N, Ciullo V, Hong E, Busatto G, Zanetti MV, Serpa MH, Cervenka S, Kelly S, Grotegerd D, Sacchet MD, Veer IM, Li M, Wu MJ, Irungu B, Walton E, Thompson PM.

Mach Learn Med Imaging. 2017 Sep;10541:371-378. doi: 10.1007/978-3-319-67389-9_43. Epub 2017 Sep 7.

32.

Vitamin D, Folate and the Intracranial Volume in Schizophrenia and Bipolar Disorder and Healthy Controls.

Gurholt TP, Osnes K, Nerhus M, Jørgensen KN, Lonning V, Berg AO, Andreassen OA, Melle I, Agartz I.

Sci Rep. 2018 Jul 17;8(1):10817. doi: 10.1038/s41598-018-29141-y.

33.

Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives.

Juvodden HT, Alnæs D, Lund MJ, Agartz I, Andreassen OA, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S.

Sleep. 2018 Oct 1;41(10). doi: 10.1093/sleep/zsy145.

PMID:
30016530
34.

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2018 Nov 1;84(9):644-654. doi: 10.1016/j.biopsych.2018.04.023. Epub 2018 May 14.

35.

A population study of Norwegian psychiatric patients referred for clinical brain scanning.

Beyer MK, Dalaker TO, Greve OJ, Pignatiello SE, Agartz I.

BJPsych Open. 2018 May 8;4(3):149-156. doi: 10.1192/bjo.2018.16. eCollection 2018.

36.

Reliability and validity of the self-report version of the apathy evaluation scale in first-episode Psychosis: Concordance with the clinical version at baseline and 12 months follow-up.

Faerden A, Lyngstad SH, Simonsen C, Ringen PA, Papsuev O, Dieset I, Andreassen OA, Agartz I, Marder SR, Melle I.

Psychiatry Res. 2018 Sep;267:140-147. doi: 10.1016/j.psychres.2018.05.065. Epub 2018 May 31.

PMID:
29906681
37.

Hippocampus volume reduction in psychosis spectrum could be ameliorated by vitamin D.

Gurholt TP, Nerhus M, Osnes K, Berg AO, Andreassen OA, Melle I, Agartz I.

Schizophr Res. 2018 Sep;199:433-435. doi: 10.1016/j.schres.2018.03.011. Epub 2018 Mar 16. No abstract available.

PMID:
29555212
38.
39.

No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.

Hjärpe J, Söderman E, Andreou D, Sedvall GC, Agartz I, Jönsson EG.

Psychiatry Res. 2018 May;263:30-34. doi: 10.1016/j.psychres.2018.02.036. Epub 2018 Feb 17.

PMID:
29482043
40.

Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1.

Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, Potkin SG, van Erp TGM, Macciardi F, Ehrlich S, Ho BC, Sponheim SR, Wang L, Stephen JM, Mayer AR, Hanlon FM, Jung RE, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, Tamminga CA, Andreassen OA, Agartz I, Westlye LT, Sui J, Du Y, Turner JA, Liu J.

Schizophr Bull. 2019 Jan 1;45(1):222-232. doi: 10.1093/schbul/sby010.

PMID:
29474680
41.

Cortical thickness abnormalities in bipolar disorder patients with a lifetime history of auditory hallucinations.

Mørch-Johnsen L, Nerland S, Jørgensen KN, Osnes K, Hartberg CB, Andreassen OA, Melle I, Nesvåg R, Agartz I.

Bipolar Disord. 2018 Nov;20(7):647-657. doi: 10.1111/bdi.12627. Epub 2018 Feb 13.

PMID:
29441665
42.

Cortical thickness, cortical surface area and subcortical volumes in schizophrenia and bipolar disorder patients with cannabis use.

Hartberg CB, Lange EH, Lagerberg TV, Haukvik UK, Andreassen OA, Melle I, Agartz I.

Eur Neuropsychopharmacol. 2018 Jan;28(1):37-47. doi: 10.1016/j.euroneuro.2017.11.019. Epub 2017 Dec 15.

PMID:
29254657
43.

The Neural Correlates of Negative Symptoms in Schizophrenia: Examples From MRI Literature.

Mørch-Johnsen L, Agartz I, Jensen J.

Clin EEG Neurosci. 2018 Jan;49(1):12-17. doi: 10.1177/1550059417746214. Review.

PMID:
29243527
44.

Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group.

Kelly S, Jahanshad N, Zalesky A, Kochunov P, Agartz I, Alloza C, Andreassen OA, Arango C, Banaj N, Bouix S, Bousman CA, Brouwer RM, Bruggemann J, Bustillo J, Cahn W, Calhoun V, Cannon D, Carr V, Catts S, Chen J, Chen JX, Chen X, Chiapponi C, Cho KK, Ciullo V, Corvin AS, Crespo-Facorro B, Cropley V, De Rossi P, Diaz-Caneja CM, Dickie EW, Ehrlich S, Fan FM, Faskowitz J, Fatouros-Bergman H, Flyckt L, Ford JM, Fouche JP, Fukunaga M, Gill M, Glahn DC, Gollub R, Goudzwaard ED, Guo H, Gur RE, Gur RC, Gurholt TP, Hashimoto R, Hatton SN, Henskens FA, Hibar DP, Hickie IB, Hong LE, Horacek J, Howells FM, Hulshoff Pol HE, Hyde CL, Isaev D, Jablensky A, Jansen PR, Janssen J, Jönsson EG, Jung LA, Kahn RS, Kikinis Z, Liu K, Klauser P, Knöchel C, Kubicki M, Lagopoulos J, Langen C, Lawrie S, Lenroot RK, Lim KO, Lopez-Jaramillo C, Lyall A, Magnotta V, Mandl RCW, Mathalon DH, McCarley RW, McCarthy-Jones S, McDonald C, McEwen S, McIntosh A, Melicher T, Mesholam-Gately RI, Michie PT, Mowry B, Mueller BA, Newell DT, O'Donnell P, Oertel-Knöchel V, Oestreich L, Paciga SA, Pantelis C, Pasternak O, Pearlson G, Pellicano GR, Pereira A, Pineda Zapata J, Piras F, Potkin SG, Preda A, Rasser PE, Roalf DR, Roiz R, Roos A, Rotenberg D, Satterthwaite TD, Savadjiev P, Schall U, Scott RJ, Seal ML, Seidman LJ, Shannon Weickert C, Whelan CD, Shenton ME, Kwon JS, Spalletta G, Spaniel F, Sprooten E, Stäblein M, Stein DJ, Sundram S, Tan Y, Tan S, Tang S, Temmingh HS, Westlye LT, Tønnesen S, Tordesillas-Gutierrez D, Doan NT, Vaidya J, van Haren NEM, Vargas CD, Vecchio D, Velakoulis D, Voineskos A, Voyvodic JQ, Wang Z, Wan P, Wei D, Weickert TW, Whalley H, White T, Whitford TJ, Wojcik JD, Xiang H, Xie Z, Yamamori H, Yang F, Yao N, Zhang G, Zhao J, van Erp TGM, Turner J, Thompson PM, Donohoe G.

Mol Psychiatry. 2018 May;23(5):1261-1269. doi: 10.1038/mp.2017.170. Epub 2017 Oct 17.

45.

Biclustered Independent Component Analysis for Complex Biomarker and Subtype Identification from Structural Magnetic Resonance Images in Schizophrenia.

Gupta CN, Castro E, Rachkonda S, van Erp TGM, Potkin S, Ford JM, Mathalon D, Lee HJ, Mueller BA, Greve DN, Andreassen OA, Agartz I, Mayer AR, Stephen J, Jung RE, Bustillo J, Calhoun VD, Turner JA.

Front Psychiatry. 2017 Sep 26;8:179. doi: 10.3389/fpsyt.2017.00179. eCollection 2017.

46.

Psychotic patients who used cannabis frequently before illness onset have higher genetic predisposition to schizophrenia than those who did not.

Aas M, Melle I, Bettella F, Djurovic S, Le Hellard S, Bjella T, Ringen PA, Lagerberg TV, Smeland OB, Agartz I, Andreassen OA, Tesli M.

Psychol Med. 2018 Jan;48(1):43-49. doi: 10.1017/S0033291717001209. Epub 2017 Oct 2.

PMID:
28967348
47.

Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study.

Mørch RH, Dieset I, Faerden A, Hope S, Aas M, Nerhus M, Gardsjord ES, Haram M, Falk RS, Joa I, Morken G, Agartz I, Aukrust P, Djurovic S, Melle I, Ueland T, Andreassen OA.

Acta Psychiatr Scand. 2017 Oct;136(4):400-408. doi: 10.1111/acps.12783. Epub 2017 Aug 16.

PMID:
28815548
48.

Tracking salience in young people: A psychometric field test of the Aberrant Salience Inventory (ASI).

Raballo A, Cicero DC, Kerns JG, Sanna S, Pintus M, Agartz I, Pintus E, Corrias I, Lai V, Petretto DR, Carta MG, Preti A.

Early Interv Psychiatry. 2019 Feb;13(1):64-72. doi: 10.1111/eip.12449. Epub 2017 Jul 18.

PMID:
28719056
49.

Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders.

Doan NT, Kaufmann T, Bettella F, Jørgensen KN, Brandt CL, Moberget T, Alnæs D, Douaud G, Duff E, Djurovic S, Melle I, Ueland T, Agartz I, Andreassen OA, Westlye LT.

Neuroimage Clin. 2017 Jun 9;15:719-731. doi: 10.1016/j.nicl.2017.06.014. eCollection 2017.

50.

Distinguishing early and late brain aging from the Alzheimer's disease spectrum: consistent morphological patterns across independent samples.

Doan NT, Engvig A, Zaske K, Persson K, Lund MJ, Kaufmann T, Cordova-Palomera A, Alnæs D, Moberget T, Brækhus A, Barca ML, Nordvik JE, Engedal K, Agartz I, Selbæk G, Andreassen OA, Westlye LT; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2017 Sep;158:282-295. doi: 10.1016/j.neuroimage.2017.06.070. Epub 2017 Jun 27.

PMID:
28666881

Supplemental Content

Loading ...
Support Center